Physician profile
Nariman Nezami
NPI 1619381506
$411,678.82
in general payments reported to CMS, 2019-2025
28 companies · $273K in 2025
The $273K reported for 2025 was more than what 99% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $495 · 2021: $2,708 · 2022: $2,729 · 2023: $8,629 · 2024: $124K · 2025: $273K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $338K · Travel and Lodging: $39K · Food and Beverage: $16K · Consulting Fee: $8,706 · Honoraria: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $338,375.00 |
| Travel and Lodging | $39,479.27 |
| Food and Beverage | $16,186.16 |
| Consulting Fee | $8,706.25 |
| Honoraria | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $389,544.88 | 2021-2025 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), General - Embolics, General - Therapies |
| Medtronic, INC. | $6,884.14 | 2021-2025 | Kyphon Express II Kyphopak Tray, Concertotm, Synchromedii |
| Trisalus Life Sciences, INC. | $4,880.06 | 2023-2024 | Trinav Infusion System |
| Guerbet LLC | $3,149.91 | 2024-2025 | Lipiodol, Lipiodol |
| Angiodynamics, INC. | $1,543.65 | 2021-2025 | Alphavac |
| Penumbra, INC. | $748.56 | 2022-2025 | Indigo System, Penumbra System, Ruby Coil |
| Provepharm INC. | $700.00 | 2023 | |
| Abbott Laboratories | $623.82 | 2021-2025 | Perclose Proglide, Jeti Peripheral Catheter, Perclose Prostyle |
| Stryker Corporation | $483.23 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Bard Peripheral Vascular, INC. | $466.50 | 2022-2025 | Pristine |
| Inari Medical, INC. | $444.54 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $285.06 | 2021-2025 | Azur Cx Detachable, Angio-Seal, Navicross |
| Cook Medical LLC | $267.85 | 2020 | |
| Instylla, INC. | $232.77 | 2024-2025 | Instylla Delivery Kit, Instylla Microcatheter |
| Xact Robotics Ltd | $177.91 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $170.69 | 2022 | |
| Sirtex Medical INC | $163.47 | 2023-2024 | Sir-Spheres Microspheres |
| Becton, Dickinson and Company | $139.92 | 2023 | Pristine |
| Madrigal Pharmaceuticals | $136.19 | 2025 | Rezdiffra |
| Ethicon US, LLC | $129.53 | 2022-2024 | Neuwave |
| Avanos Medical | $117.54 | 2023 | Generator |
| Balt USA, LLC | $113.80 | 2024 | Prestige Coil System |
| Medtronic USA, INC. | $82.00 | 2020 | |
| Mallinckrodt Hospital Products INC. | $79.72 | 2025 | Terlivaz |
| Blackswan Vascular, INC. | $68.16 | 2022 | |
| Okami Medical, INC. | $26.88 | 2025 | Lobo |
| W. L. Gore & Associates, INC. | $18.04 | 2025 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nariman Nezami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.